Oncology Institute (DFPH) Return on Capital Employed (2021 - 2026)
Oncology Institute's (DFPH) quarterly Return on Capital Employed came in at 37.53% in Q1 2026, up 1031.0% YoY from 3.32% in Q1 2025, and up 3.09% on a QoQ basis from 38.73% in Q4 2025.
Oncology Institute (DFPH) Return on Capital Employed (2021 - 2026) Analysis & Trends
Oncology Institute (DFPH) has 6 years of Return on Capital Employed data on file, last reported at 37.53% in Q1 2026.
- Quarterly Return on Capital Employed rose 1031.0% year-over-year to 37.53% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 37.53% (up 1031.0% YoY) and the FY2025 annual result came in at 36.92%, up 640.0% from the prior year.
- Return on Capital Employed advanced to 37.53% in Q1 2026, from 38.73% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 33.72% in Q4 2022 to a low of 49.24% in Q2 2022.
- A 5-year average of 43.34% and a median of 44.18% in 2023 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2022 — Return on Capital Employed tumbled 4452 bps — and 2026, when it jumped 1031 bps.
- Tracing DFPH's Return on Capital Employed over 5 years: stood at 33.72% in 2022, then dropped by 28 bps to 43.02% in 2023, then fell by 13 bps to 48.59% in 2024, then increased by 20 bps to 38.73% in 2025, then advanced by 3 bps to 37.53% in 2026.
- The last three Return on Capital Employed figures came in at 37.53% (Q1 2026), 38.73% (Q4 2025), and 42.76% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 88.19 Bn | 90.61 Bn | 15.19 Bn | -16.87% |
| 2 | Tenet Healthcare | 21.59 Bn | 21.56 Bn | 4.45 Bn | 17.89% |
| 3 | Encompass Health | 12.19 Bn | 12.86 Bn | 1.34 Bn | 2.50% |
| 4 | Davita | 11.52 Bn | 12.39 Bn | 1.16 Bn | 14.43% |
| 5 | Ensign | 10.59 Bn | 10.27 Bn | 306.24 Mn | 9.75% |
| 6 | Universal Health Services | 8.79 Bn | 8.72 Bn | 3.29 Bn | 16.45% |
| 7 | Pacs | 7.04 Bn | 6.88 Bn | 338.46 Mn | 8.91% |
| 8 | Chemed | 6.96 Bn | 6.92 Bn | 221.47 Mn | 28.21% |
| 9 | Concentra Group Holdings Parent | 4.52 Bn | 4.38 Bn | 192.10 Mn | 14.52% |
| 10 | Oncology Institute | 201.94 Mn | 160.85 Mn | 27.17 Mn | -33.32% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -33.32% |
| Mar 31, 2026 | -37.53% |
| Dec 31, 2025 | -38.73% |
| Sep 30, 2025 | -42.76% |
| Jun 30, 2025 | -48.29% |
| Mar 31, 2025 | -47.84% |
| Dec 31, 2024 | -48.59% |
| Sep 30, 2024 | -47.86% |
| Jun 30, 2024 | -40.49% |
| Mar 31, 2024 | -38.56% |
| Dec 31, 2023 | -43.02% |
| Sep 30, 2023 | -45.27% |
| Jun 30, 2023 | -46.77% |
| Mar 31, 2023 | -44.18% |
| Dec 31, 2022 | -33.72% |
| Sep 30, 2022 | -47.91% |
| Jun 30, 2022 | -49.24% |
| Mar 31, 2022 | -36.08% |
| Dec 31, 2021 | -24.51% |
| Sep 30, 2021 | -5.62% |